Overview
Beckley Psytech is a UK-based clinical-stage company developing short-duration psychedelic therapies, with a lead program using intranasal psilocybin (BPL-003) for treatment-resistant depression intended to reduce session time versus oral formulations. They are part of the Beckley Foundation's broader mission to advance psychedelic science.
More in Psychedelics
Latest industry news
Generative AI Is Closing the Gap on Brain-Computer Interface Accuracy and Resolution
2026-11-11 ยท Research
Spiking Neural Networks Emerge as a Viable Shield Against Signal Noise in Brain-Computer Interfaces
2026-11-10 ยท Research
China's Brain-Reading Device Hits 94% Mind-Typing Accuracy Over a Full Day of Use
2026-11-09 ยท Research
Wearable Brain-Computer Interfaces Are Closer to Mainstream Than You Think
2026-11-08 ยท Industry
Company details
Category
๐ Psychedelics
Location
Oxford, UK
Funding
Series B ยท $80M
Website
www.beckleypsytech.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ